3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Weight Loss
2
Stomach Neoplasms
2
Malnutrition
2
Esophageal Neoplasms
2
Pituitary Neoplasms
1
Periampullary Tumors
1
Pancreatic Neuroendocrine Tumor G2
1
Pancreatic Neoplasms
1
Lymphocele
1
Endocrine System Diseases
1
Duodenal Neoplasms
1
Breast Neoplasms
1
Acromegaly
1
Interventions
Standard of Care
1
Octreotide
1
Fenestration, Labyrinth
1
Bandages
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Lymphocele
×
Octreotide
×
Clear all
NCT03791736
2022-07-28
SANDOSTATINE
Institut Cancerologie de l'Ouest
Phase NA
Terminated
4 enrolled